IDiyas

For the Inventor, By the Inventor

Herzliya, Israel

Prilenia Neurotherapeutics Ltd.


USPTO Granted Patents = 18



Trademarks = 2

Forward Citations = 11

Loading Chart...
Loading Chart...

48 inventors (with patents filed for the assignee):

goldMedal Michael Hayden (10 out of 12 patents)

silverMedal Michal Geva (8 out of 8 patents)

bronzeMedal Eli Eyal (4 out of 5 patents)

4.  Merav Bassan (4 out of 10 patents)

5.  Ralph Laufer (3 out of 4 patents)

6.  Aric Orbach (3 out of 3 patents)

7.  Juha-Matti Savola (2 out of 3 patents)

8.  Spyridon Papapetropoulos (2 out of 2 patents)

9.  Malle Schmidt (2 out of 4 patents)

10.  Marit Laos (2 out of 4 patents)

11.  Ants Maasalu (2 out of 5 patents)

12.  Kalle Kaljuste (2 out of 3 patents)

13.  Anna Kristina Sveinsdotter Teige Wickenberg (2 out of 3 patents)

14.  Malle Päri (2 out of 3 patents)

15.  Ilya Bezprozvanny (2 out of 4 patents)


18 patents:

1. 12390456 - Pridopidine for treating Huntington's disease (2025-08-19),
2. 12357624 - Low dose pridopidine for Parkinson's Disease and other diseases associated with parkinsonism (2025-07-15),
3. 12102627 - Use of pridopidine for treating rett syndrome (2024-10-01),
4. 12036213 - Pridopidine for treating drug induced dyskinesias (2024-07-16),
5. 11826361 - Use of pridopidine for treating dystonias (2023-11-28),
6. 11738012 - Treatment of neurodegenerative eye disease using pridopidine (2023-08-29),
7. 11471449 - Use of pridopidine to improve cognitive function and for treating Alzheimer's disease (2022-10-18),
8. 11452694 - High concentration dosage forms of pridopidine (2022-09-27),
9. 11406625 - Method of treating amyotrophic lateral sclerosis with pridopidine (2022-08-09),
10. 11234973 - Use of pridopidine for the treatment of fragile X syndrome (2022-02-01),
11. 11207310 - Use of pridopidine for treating functional decline (2021-12-28),
12. 11207308 - Pharmaceutical compositions for combination therapy (2021-12-28),
13. 11141412 - Analogs of pridopidine, their preparation and use (2021-10-12),
14. 11090297 - Pridopidine for treating huntington's disease (2021-08-17),
15. 11000519 - Pridopidine for treating drug induced dyskinesias (2021-05-11),
Prilenia Neurotherapeutics Ltd. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel treatments for neurodegenerative and neurodevelopmental disorders. With a focus on diseases such as Huntington's disease, amyotrophic lateral sclerosis (ALS), and Parkinson's disease, Prilenia aims to improve the lives of patients and their families. By leveraging innovative science and strategic partnerships, the company is committed to bringing transformative therapies to the market.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

18 Patents

#10 in Herzliya

#319 in Israel

#33,147 in the World

...
Herzliya, Israel

Prilenia Neurotherapeutics Ltd.

Forward Citations = 11

48 inventors:

goldMedal Michael Hayden (10 out of 12 patents)

silverMedal Michal Geva (8 out of 8 patents)

bronzeMedal Eli Eyal (4 out of 5 patents)

4.  Merav Bassan (4 out of 10 patents)

5.  Ralph Laufer (3 out of 4 patents)

Please report any incorrect information to support@idiyas.com
Loading…